Canadian Headache Society Guideline: acute drug therapy for migraine headache
- PMID: 23968886
Canadian Headache Society Guideline: acute drug therapy for migraine headache
Abstract
Objectives: The primary objective of this guideline is to assist the practitioner in choosing an appropriate acute medication for an individual with migraine, based on current evidence in the medical literature and expert consensus. It is focused on patients with episodic migraine ( headache on ≤ 14 days a month).
Methods: A detailed search strategy was used to find a relevant meta-analyses, systematic reviews and randomized double-blind controlled trials. Recommendations were graded with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Working Group, using a consensus group. In addition, a general literature review and expert consensus were used for aspects of acute therapy for which randomized controlled trials were not available.
Results: Twelve acute medications received a strong recommendation for use in acute migraine therapy (almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, zomitriptan, ASA, ibuprofen, naproxen sodium, diclofenac potassium, and acetaminophen). Four received a weak recommendation for use (dihydroergotamine, ergotamine, codeine-containing combination analgesics, and tramadol- containing medications). Three of these were NOT recommended for routine use (ergotamine and codeine- and tramadol- containing medications). Strong recommendations were made to avoid use of butorphanol and butalbital- containing medications. Metoclopramide and domperidone were strongly recommended for use when necessary. Our analysis also resulted in the formulation of eight general acute migraine management strategies. These were grouped into: 1) two mild-moderate attack strategies, 2) two moderate-severe attack or NSAID failure strategies, 3) three refractory migraine strategies, and 4) a vasoconstrictor unresponsive-contraindicated strategy. Additional were developed for menstrual migraine during pregnancy, and migraine during lactation.
Conclusion: This guideline provides evidence-based advice on acute pharmacological migraine therapy, and should be helpful to both health professionals and patients, The available medications have been organized into a series of strategies based on patient clinical features. These strategies may help practitioners make appropriate acute medication choices for patients with migraine.
Similar articles
-
Acute Migraine Treatment in Adults.Headache. 2015 Jun;55(6):778-93. doi: 10.1111/head.12550. Epub 2015 Apr 15. Headache. 2015. PMID: 25877672 Review.
-
The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies.Headache. 2015 Jan;55(1):3-20. doi: 10.1111/head.12499. Headache. 2015. PMID: 25600718 Review.
-
Acute Migraine Treatment.Continuum (Minneap Minn). 2015 Aug;21(4 Headache):953-72. doi: 10.1212/CON.0000000000000192. Continuum (Minneap Minn). 2015. PMID: 26252584 Review.
-
Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.Headache. 2012 Apr;52(4):530-43. doi: 10.1111/j.1526-4610.2011.02039.x. Epub 2011 Nov 21. Headache. 2012. PMID: 22103635 Clinical Trial.
-
Canadian Headache Society guideline for migraine prophylaxis.Can J Neurol Sci. 2012 Mar;39(2 Suppl 2):S1-59. Can J Neurol Sci. 2012. PMID: 22683887
Cited by
-
Clinical pearls for management of migraines.Can Fam Physician. 2024 May;70(5):325-327. doi: 10.46747/cfp.7005325. Can Fam Physician. 2024. PMID: 38744521 Free PMC article. No abstract available.
-
The Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) versus Transcranial Direct-Current Stimulation (tDCS) on Migraine Headaches: A Randomized Clinical Trial.Adv Biomed Res. 2024 Jan 30;13:7. doi: 10.4103/abr.abr_142_23. eCollection 2024. Adv Biomed Res. 2024. PMID: 38525392 Free PMC article.
-
The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review.Pain Ther. 2024 Jun;13(3):319-346. doi: 10.1007/s40122-024-00581-x. Epub 2024 Mar 6. Pain Ther. 2024. PMID: 38446344 Free PMC article. Review.
-
Real-world observations and impacts of Chinese herbal medicine for migraine: results of a registry-based cohort study.Front Pharmacol. 2024 Feb 2;15:1330589. doi: 10.3389/fphar.2024.1330589. eCollection 2024. Front Pharmacol. 2024. PMID: 38370478 Free PMC article.
-
Efficacy and safety of intranasal agents for the acute treatment of migraine: a systematic review and network meta-analysis.J Headache Pain. 2023 Sep 18;24(1):129. doi: 10.1186/s10194-023-01662-6. J Headache Pain. 2023. PMID: 37723470 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical